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Abstract Acylglycerol kinase (AGK) has been reported to
promote a malignant phenotype and enhance the development
of cancer stem cells. However, the clinical value of AGK in
cancer remains unclear. This study aimed to investigate the
expression and clinicopathological significance of AGK in
nasopharyngeal carcinoma (NPC). AGKwas significantly up-
regulated in NPC cell lines and clinical specimens as indicated
by real-time PCR and Western blotting. Among the AGK-
positive cases, 52/114 (45.6 %) of the archived human NPC
specimens expressed high levels of AGK. High expression of
AGK was associated with significantly shorter overall and
disease-free survival (P<0.001 and P=0.002; log-rank test)
and was an independent prognostic factor for overall survival
(P=0.041; multivariate Cox analysis). High AGK expression
was associated with lymph node metastasis (P<0.001; chi-
squared test) and was an independent predicted factor for
lymph node metastasis in NPC (P=0.032; multivariate logis-
tic analysis). AGK is overexpressed and associated with dis-
ease progression and lymph node metastasis in NPC. AGK
has potential as a novel prognostic factor for overall survival
in NPC.
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Introduction
Nasopharyngeal carcinoma (NPC) is a malignant cancer arising
from the epithelial surface of the nasopharynx. NPC is especial-
ly common in Southern China and Southeast Asia [1, 2], with
the highest incidence in the world observed among the
Cantonese-speaking population in Guangdong Province [3,
4]. As a result of technical improvements in radiotherapy deliv-
ery such as intensity-modulated radiation therapy (IMRT), ex-
cellent local control can now be achieved; however, local re-
currence and metastasis remain the leading causes of mortality
in advanced stage disease [5]. Previous clinical study has dem-
onstrated that the neck nodal status is an independent prognos-
tic factor that affects overall survival in patients with NPCwith-
out distant metastasis [6]. Involvement of both cervical lymph
nodes and retropharyngeal lymph nodes has prognostic value
for N1 patients with NPC [7]. Therefore, identification of mo-
lecular markers for prognosis and lymph node metastasis may
help to improve the overall survival rate and design individual-
ized therapeutic regimens in patients with NPC.
Acylglycerol kinase (AGK) has been found to be abun-
dantly expressed in the heart, muscle, kidney, and brain [8].
By acting as a lipid kinase, AGK catalyzes the phosphoryla-
tion of acylglycerol to generate lysophosphatidic acid (LPA)
[8–11], which is known to be involved in tumor progression
[12], invasion, neovascularization, and metastasis [13]. AGK
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was reported to be overexpressed in prostate, breast, esopha-
geal squamous cell carcinoma (ESCC), and oral squamous
cell carcinoma [8, 14–17]. Bektas et al. demonstrated that
overexpression of AGK enhanced the proliferation and migra-
tion of prostate cancer cells in vitro [8]. AGK expression was
significantly associated with the primary tumor Gleason grade
and prostatic capsular invasion in prostate cancer [14]. Wang
et al. showed that AGK promotes cell proliferation and tumor-
igenicity in breast cancer [15]. Overexpression of AGK pro-
moted a stem cell-like phenotype in human ESCC cells
in vivo and tumorigenicity in vitro [16]. Recently, AGK is
reported to promote cell proliferation and cell cycle progres-
sion in oral squamous cell carcinoma [17]. Taken together,
these findings indicate that AGK may play an essential role
in the progression and development of cancer. However, the
expression and clinical significance of AGK in NPC remain
unclear.
In the present study, we aimed to investigate the expression
of AGK in NPC and explore its relationship with the clinico-
pathological features and prognosis of patients with NPC. We
demonstrate that AGK is significantly upregulated in NPC
and overexpression of AGK is closely associated with the
clinical stage, T, N, M classification, histological differentia-
tion, and lymph node metastasis. Moreover, Cox regression
analysis revealed that AGKmay be considered as an indepen-
dent biomarker of prognosis in NPC. Multivariate logistic
analysis revealed that AGK may also represent an indepen-
dent biomarker for lymph nodemetastasis in NPC. Collective-
ly, these findings strongly suggest that AGK plays a signifi-
cant role in NPC progression and lymph node metastasis.
Materials and methods
Cell lines
The primary normal nasopharyngeal epithelial cell line NP69
was obtained fromDr. George SWTsao, Cancer Center, Hong
Kong University, Hong Kong, and cultured in keratinocyte/
serum-free medium (Invitrogen, Grand Island, NY, USA). Na-
sopharyngeal cancer cell lines (CNE-1, CNE-2, SUNE-1, 6-
10B, 5-8F, and HK-1) were cultured in DMEM medium
(Gibco, Grand Island, NY, USA) supplemented with 10 %
FBS (HyClone, Logan, UT, USA).
Tissue specimens and patient information
NPC paraffin-embedded specimens from a total of 114 pa-
tients who had been histopathologically and clinically diag-
nosed with NPC at the Cancer Center of Sun Yat-sen Univer-
sity (Guangzhou, China) between 2007 and 2010 were used in
the present study. Prior patient consent and approval from Sun
Yat-sen University Cancer Center Institutional Review Board
were obtained. Tumor grade and stage were defined according
to the seventh edition of the UICC staging system. One patient
(0.9 %) had stage I disease, 14 (12.3 %) had stage II, 48
(42.1 %) had stage III, and 51 (44.7 %) had stage IV. All of
the NPC patients received radiotherapy or concurrent chemo-
radiotherapy, while distant metastasis NPC patients
underwent a long period of induction chemotherapy to control
the metastatic lesions. The clinicopathological features of the
patients are summarized in Table 1. The follow-up time for the
primary NPC cohort ranged from 17 to 77 months, and the
median follow-up time was 60 months. The percentage of
tumor purity in sections adjacent to the regions used for
RNA extraction was estimated during routine histopathologi-
cal analysis.
The freshly frozenNPC tissues and noncancerous nasopha-
ryngeal tissue were obtained, after informed consent, from the
patients who underwent nasopharyngeal biopsy before treat-
ment. Two paired tumor samples and the adjacent noncancer-
ous tissues (N1–2) were from the same patients, while five
noncancerous tissues (T3–7) were from the additional tumor
samples. All the tissues were pathologically diagnosed in Can-
cer Center of Sun Yat-sen University.
Real-time PCR
Total RNA was extracted from the cell lines and freshly
frozen tissues using TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions,
treated with RNase-free DNase, and 2 μg was used for
complementary DNA (cDNA) synthesis with random
hexamers. For PCR amplification of AGK cDNA using
AGK-specific primers, initial amplification was performed
with denaturation at 95 °C for 10 min, followed by 28
cycles of denaturation at 95 °C for 60 s, primer annealing
at 58 °C for 30 s, and primer extension at 72 °C for 30 s.
Upon completion of the cycling steps, a final extension
step was performed at 72 °C for 5 min; then, the reaction
mixtures were stored at 4 °C. Real-time PCR was per-
formed to measure the relative fold change in AGK mes-
senger RNA (mRNA) expression in each of the primary
tumor specimens relative to the normal nasopharyngeal tis-
sues (collected from different patients). The primers and
probe were designed using Primer Express v2.0 (Applied
Biosystems), and the sequences were as follows: AGK for-
ward, 5′-CGAAGGCTTGCGTCCTACTG-3′ and reverse,
5′-TGGTGGACAGCTGCACATCT-3′ and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) forward 5 ′-
AAGGTCATCCCTGAGCTGAA-3 ′ and reverse 5′-
TGACAAAGTGGTCGTTGAGG-3′. Expression data were
normalized to the geometric mean of GAPDH and calcu-
lated as 2−[(Ct of AGK)−(Ct of GAPDH)], where Ct represents
the threshold cycle for each transcript; all experiments were
performed in triplicate.
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Western blotting
Cells at 70 to 80 % confluence were washed twice with ice-
cold phosphate-buffered saline (PBS) and lysed on ice in
radioimmunoprecipitation assay buffer (RIPA; Cell Signaling
Technology, Danvers, MA, USA) containing complete prote-
ase inhibitor cocktail (Roche Applied Sciences, Mannheim,
Germany), then heated for 5 min at 100 °C. Freshly human
tissue samples were ground to a powder in liquid nitrogen and
lysed in sodium dodecyl sulfate (SDS)-PAGE sample buffer.
Equal amounts of protein (20 μg) were separated on 10.5 %
SDSpolyacrylamide gels and transferred to PVDFmembranes
(Immobilon P; Millipore, Bedford, MA, USA). The mem-
branes were blocked with 5 % fat-free milk in Tris-buffered
saline containing 0.1 % Tween-20 (TBST) for 1 h at room
temperature, incubated with anti-AGK-2 antibody (1:1000,
ab96507; Abcam, USA) overnight at 4 °C. α-Tubulin mouse
monoclonal antibody (1:1000, Sigma, St. Louis, MO, USA)
was used as an internal loading control. Protein bands were
detected using ECL prime Western blotting detection reagent
Table 1 Association between
AGK expression and the
clinicopathological features of
nasopharyngeal cancer
Feature No. of patients AGK expression P value
Low High
Gender
Male 82 (71.9 %) 45 (54.9 %) 37 (45.1 %) 0.866
Female 32 (28.1 %) 17 (53.1 %) 15 (46.9 %)
Age (years)
≤45 65 (57.0 %) 38 (58.5 %) 27 (41.5 %) 0.314
>45 49 (43.0 %) 24 (50.0 %) 25 (50.0 %)
T classification
T1 1 (0.90 %) 1 (100 %) 0 (0.0 %) 0.012
T2 19 (16.7 %) 16 (84.2 %) 3 (15.8 %)
T3 54 (47.4 %) 29 (53.7 %) 25 (46.3 %)
T4 40 (35.1 %) 16 (40.0 %) 24 (60.0 %)
N classification
N0 19 (16.7 %) 18 (94.7 %) 1 (5.3 %) <0.001
N1 49 (43.0 %) 32 (65.3 %) 17 (34.7 %)
N2 33 (28.9 %) 10 (30.3 %) 23 (69.7 %)
N3 13 (11.4 %) 2 (15.4 %) 11 (84.6 %)
M classification
M0 108 (94.7 %) 62 (54.7 %) 46 (42.6 %) 0.006
M1 6 (5.3 %) 2 (33.3 %) 4 (66. 7 %)
Clinical stage
I 1 (0.90 %) 1 (100.0 %) 0 (0.0 %) <0.001
II 14 (12.3 %) 10 (71.4 %) 4 (28.6 %)
III 48 (42.1 %) 29 (60.4 %) 19 (39.6 %)
IV 51 (44.7 %) 18 (35.3 %) 33 (64.7 %)
IV classification
IVa 35 (68.6 %) 14 (40.0 %) 21 (60.0 %)
IVb 10 (19.6 %) 2 (20.0 %) 8 (80.0 %) 0.080
IVc 6 (11.8 %) 2 (33.3 %) 4 (66.7 %)
Histological differentiation
U 85 (74.6 %) 36 (42.4 %) 49 (57.6 %)
D 29 (25.4 %) 26 (89.7 %) 3 (10.3 %) <0.001
Lymph node metastasis
Yes 95 (83.3 %) 44 (46.3 %) 51 (53.7 %) <0.001
No 19 (16.7 %) 18 (94.7 %) 1 (5.3 %)
Vital status
Alive 96 (84.2 %) 61 (63.5 %) 35 (36.5 %) <0.001
Dead 18 (15.8 %) 1 (5.6 %) 17 (94.4 %)
D differentiated nonkeratinized carcinoma, U undifferentiated nonkeratinized carcinoma
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(Amersham Biosciences Europe, Freiberg, Germany) accord-
ing to the manufacturer’s instructions.
Immunohistochemical analysis
Briefly, 4-μm-thick paraffin sections were deparaffinized in
xylene, rehydrated, microwaved in EDTA antigen retrieval
buffer, treated with 3 % hydrogen peroxide in methanol to
quench endogenous peroxidase activity, incubated with 1 %
bovine serum albumin to block nonspecific binding, and then
incubated with anti-AGK-2 rabbit polyclonal antibody (1:100;
ab96507; Abcam) overnight at 4 °C. Normal goat serum was
used as a negative control. After washing, the tissue sections
were incubated with a biotinylated anti-rabbit secondary anti-
body (Abcam), followed by streptavidin-horseradish peroxi-
dase complex (Abcam), developed using 3-amino-9-ethyl car-
bazole, counterstained with 10 % Mayer’s hematoxylin,
dehydrated, and mounted in Crystal Mount (Company).
Twenty cases were used for normal controls. The percentage
of positively stained tumor cells was scored as 1 (<25 % pos-
itive tumor cells), 2 (25–50 %), 3 (50–75 %), or 4 (>75 %).
The staining intensity was graded as 0 (no staining), 1 (weak
staining, light yellow), 2 (moderate staining, yellow brown),
or 3 (strong staining, brown). The overall staining score was
determined by multiplying the score for the percentage of
positively stained tumor cells by the score for the staining
intensity (the possible scores were 0, 1, 2, 3, 4, 6, 8, 9, and
12), and the scores determined by two independent investiga-
tors were averaged for each sample. The cutoff value for AGK
was chosen on the basis of a measure of heterogeneity using
the log-rank test with respect to overall survival (OS); a score
of ≥9 was used to define tumors with high AGK expression
and <9 with low AGK expression.
Immunohistochemical staining for protein expression in
tumor and normal tissues was quantitatively analyzed with
the AxioVision Rel.4.6 computerized image analysis system
assisted with the automatic measurement program (Carl
Zeiss). Briefly, the stained sections were evaluated at 200
magnification, and 10 representative staining fields of each
section were analyzed to verify the mean absorbance, which
represents the strength of staining signals as measured per
positive pixels. The mean absorbance data were statistically
analyzed using t test to compare the average mean absorbance
difference between different groups of tissues, and P<0.05
was considered significant.
Statistical analysis
All statistical analyses were performed using SPSS 16.0. The
chi-squared test was used to investigate the relationship be-
tween AGK expression and the clinicopathologic features of
NPC. Bivariate correlations between study variables were
evaluated using the Spearman’s rank correlation analysis.
Survival curves were plotted using the Kaplan-Meier method
and compared using the log-rank test. Clinicopathological
characteristics that are extensively used to predict prognosis
in clinical practice and AGK expression were evaluated using
univariate analysis and in multivariate Cox regression analy-
ses using a Cox proportional hazards model with forward
selection. Multivariate logistic regression analysis was per-
formed to identify the predictive factor for lymph node me-
tastasis in NPC.
In all analyses, P values <0.05 were considered statistically
significant.
Results
AGK is overexpressed in NPC cell lines and human NPC
tissues
AGKmRNAwas expressed at higher levels in all six NPC cell
lines tested than the normal nasopharyngeal epithelial line
NP69 (Fig. 1a). Similarly, high levels of AGK protein expres-
sion were observed in the NPC cell lines whereas only low
levels of AGK were detected in NP69 primary normal naso-
pharyngeal epithelial cells (Fig. 1b).
To investigate whether AGK is overexpressed in human
NPC, two paired tumor samples and the adjacent noncancer-
ous tissues from the same patients and five additional tumor
samples from other patients were subjected to quantitative
Fig. 1 Real-time PCR (a) and Western blotting (b) analysis of AGK
mRNA and protein expression in a normal nasopharyngeal cell line
(NP69) and six nasopharyngeal cancer cell lines (5-8F, CNE-1, CNE-2,
6-10B, SUNE-1, and HK-1). Error bars are standard deviation of the
mean (SD) calculated from three experiments performed in parallel
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real-time PCR and Western blotting analyses. As shown in
Fig. 2a, AGK mRNA was significantly upregulated in all of
the clinical NPC samples compared to the normal nasopha-
ryngeal tissues. The fold increases, as indicated by the tumor/
normal mRNA ratio, ranged from 3.4- to 15.6-fold. Consistent
with the mRNA levels, AGK protein expression was also
upregulated in the seven NPC tissues tested compared to the
two normal nasopharyngeal tissues (Fig. 2b). Taken together,
these results demonstrate that AGK is upregulated in NPC cell
lines and tissues.
Elevated AGK expression in NPCs associates
with advanced clinicopathological features of the patients
We further analyzed the correlation between AGK expression
and the clinicopathological features of NPC. As shown in
Fig. 2c, AGK was strong cytoplasmic staining in the NPC
tissue, while barely detectable in the normal epithelial cells.
Moreover, χ2 test showed that there was no significant asso-
ciation between AGK protein expression and patient age or
gender. However, AGKwas significantly associated with clin-
ical stage (P<0.001), T classification (P=0.012), N classifica-
tion (P<0.001) M classification (P=0.006), and histological
differentiation (P<0.001). Furthermore, IHC staining showed
that AGK expression in the NPC increased with increasing
clinical stage (Fig. 3a). Quantitative analysis also revealed that
the average mean absorbance of AGK staining in stage I–IV
tumors was statistically significantly higher than in the normal
nasopharyngeal tissues. In addition, the mean optical density
(MOD) values of AGK staining significantly increased with
progression of tumor stage from I to IV (P<0.05, Fig. 3b).
Spearman’s rank correlation analysis suggested that high
AGK expression correlated positively with clinical stage (r=
0.410,P<0.001), Tclassification (r=0.290,P=0.002), N clas-
sification (r=0.517, P<0.001), M classification (r=0.257, P=
0.006), and histological differentiation (r=0.414, P<0.001,
Table 2). However, no significant correlation was observed
between AGK expression and any other clinical feature in-
cluding age or gender. Taken together, these data indicate that
elevated AGK expression is associated with disease progres-
sion in NPC.
Elevated AGK expression in NPC associates with poorer
patient survival and prognosis
Kaplan-Meier survival analysis revealed significant associa-
tions between high AGK protein expression and poorer 5-year
OS and DFS in NPC patients (P<0.001 and P=0.002;
Fig. 4a, b). The cumulative 5-year OS rates and DFS rates
for patients with high levels of AGK expression were 67.3
and 76.9 %, respectively, in comparison to 98.4 and 93.5 %,
respectively, for patients with low or no AGK expression.
Median follow-up times for patients with low AGK expres-
sion was 58 months compared to 38 months for patients with
high AGK expression.
Multivariate Cox regression demonstrated that the expres-
sion of AGK, clinical stage, and M classification were inde-
pendent prognostic factors for poorer OS (P=0.041,P=0.040,
P=0.010, respectively; Table 3). Moreover, the prognostic
value of AGK was analyzed when the patients were stratified
according to tumor stage and T, N, and M classification. High
AGK expression was a significant prognostic factor for poorer
OS in patients with late-stage disease (stage III–IV, P<0.001;
Fig. 4c), patients with a pT3–4 classification (P<0.001,
Fig. 4d), patients with neck lymph node metastasis
(P<0.001, Fig. 4e), and patients without distant metastasis
(P<0.001, Fig. 4f). However, no statistically significant asso-
ciations were observed between AGK and OS in the early
stage disease (stage I–II), neck node negative, or distant
Fig. 2 Overexpression of AGK mRNA and protein in NPC. a AGK
mRNA expression in two paired tumor samples (T1–T2) and the
adjacent noncancerous tissues (N1–2) from the same patients, and five
additional tumor samples (T3–7) was quantified by q-PCR and normal-
ized to GAPDH. Error bars are standard deviation of the mean (SD) for
three experiments performed in parallel. *P<0.05. b Representative
Western blotting analyses of AGK protein expression in the two paired
tumor samples and adjacent noncancerous tissues from the same patients
and five additional tumor samples; α-tubulin was used as the loading
control. c Immunohistochemical analysis of AGK protein expression in
the two paired tumor samples and adjacent noncancerous tissues from the
same patients and five additional tumor samples
Tumor Biol. (2016) 37:3349–3357 3353
metastasis-positive subgroups, which may reflect the limited
number of patients in these subsets. Taken together, these
results indicate that AGK could be a useful prognostic factor
in NPC.
Elevated AGK expression in NPCs associates with lymph
node metastasis
NPC has the highest preponderance for regional lymph node
metastasis among head and neck squamous cell carcinomas.
Therefore, we evaluated the association between the expres-
sion of AGK and lymph node metastasis. In our study, there
was significant difference between the immunohistochemical
status of AGK protein expression in patients with lymph node
metastasis and patients without lymph node metastasis
(P<0.001; chi-squared test). In the subgroup of patients with
lymph node metastasis, patients with higher levels of AGK
expression had a shorter survival time compared to those with
lower AGK expression. Furthermore, multivariate logistic re-
gression analysis showed that high AGK protein expression
(P=0.032), histological differentiation (P=0.026), and T clas-
sification (P=0.015) were significantly associated with lymph
node metastasis in NPC; however, age and gender showed no
association with lymph node metastasis (Table 4). Taken to-
gether, these results suggest that AGK could play an important
role in lymph node metastasis in NPC.
Discussion
AGK has been suggested to promote tumorigenesis in
various cancers, including ESCC, hepatocellular cancer,
and breast cancer [12, 13, 18]. MTT and colony formation
assays showed that overexpression of AGK increased the
proliferation of breast cancer cells, whereas silencing AGK
drastically reduced cell proliferation [12]. In xenograft ex-
periments, ESCC cells overexpressing AGK showed an
increased growth rate and tumorigenic capacity [13]. Data
from a recent mouse model showed that the tumors
formed by AGK-transduced hepatocellular carcinoma
(HCC) cells grew more rapidly and were larger in size,
while the tumors formed by AGK-silenced cells were
smaller in both size and weight, compared to the tumors
formed by control cells [18]. Taken together, these results
confirmed that overexpression of AGK could contribute to
the proliferation of tumor cells, indicating that AGK is
involved in the progression of cancer. Consistent with
the above research, AGK was reported to be associated
with the development and progression of several types of
solid carcinoma [8, 14–18]. In the present study, we ob-
served significant associations between AGK expression
and the clinicopathologic characteristics of NPC, including
clinical stage, TNM classification, and histological
Table 2 Spearman correlation analysis between AGK and clinical
pathologic factors
Variables Spearman correlation P value
Clinical stage (I vs II vs III vs IV) 0.410 <0.001
T classification (T1 vs 2 vs 3 vs 4) 0.290 0.002
N classification (N1 vs 2 vs 3 vs 4) 0.571 <0.001
M classification (M0 vs 1) 0.257 0.006
Histological differentiation (U vs D) 0.414 <0.001
Lymph node metastasis (yes vs no) 0.362 <0.001
Vital status (live vs die) 0.425 <0.001
Gender (M vs F) 0.016 0.869
Age, years (≥45 vs <45) 0.094 0.319
M male, F female
Fig. 3 Expression of AGK in different clinical stages of NPC. a
Representative IHC images of AGK expression in normal nasopharyngeal
tissues and NPC tissues of different clinical stages. b Statistical analyses of
the averageMODof AGK staining between normal human nasopharyngeal
tissues and NPC specimens of different clinical stages. *P<0.05
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differentiation. Furthermore, survival analyses showed that
patients with higher levels of AGK expression had shorter
survival time compared to those with lower AGK expres-
sion. Additionally, Cox regression analysis further
confirmed that AGK may be an independent prognostic
factor for poor overall survival in patients with NPC. Col-
lectively, these findings indicate that AGK may contribute
to the development and progression of NPC.
Fig. 4 Five-year overall survival (a) and 5-year disease-free survival (b)
for 114 NPC patients and 5-year overall survival for the subgroups of
patients with stage III–IV disease (c), T3–T4 grade tumors (d), lymph
node metastasis (e), and patients without distant metastasis (f). P values
were calculated using the logrank test
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Invasion and metastasis are the basic biological character-
istics related to recurrence and also affect the survival of
patients with NPC [19–21]. Due to the well-developed net-
work of lymph nodes in the nasopharynx, NPC has the
highest preponderance for regional lymph node metastasis
among head and neck squamous cell carcinomas [22]. In
this study, we observed significantly higher AGK protein
expression in patients with NPC with lymph node metastasis
compared to those without lymph node metastasis. Further-
more, in the subgroup of patients with lymph node metasta-
sis, patients with higher levels of AGK expression had a
shorter survival time compared to those with lower AGK
expression. Additionally, high expression of AGK was an
independent prognostic factor for lymph node metastasis in
NPC. These results strongly support the hypothesis that high
levels of AGK expression play a critical role in promoting
lymph node metastasis in NPC. Previous studies have dem-
onstrated important associations between metastasis and
overexpression of vascular endothelial growth factor
(VEGF)/epidermal growth factor (EGF) in a variety of solid
carcinomas, including NPC [23, 24]. VEGF-induced
lymphangiogenesis and EGF-induced angiogenesis can en-
hance the development of lymphatic and vessels within and
close to tumors and thereby promote the spread of tumor
cells to regional lymph nodes [25, 26]. Moreover, overex-
pression of AGK transactivates the epidermal growth factor
receptor (EGFR) and increases prostate cancer cell migration
in vitro [8]. Additionally, the increased tumorigenicity ob-
served in response to AGK-mediated downregulation of
FOXO1 in breast cancer may be due to aberrant activation
of AKT [15], which is a major downstream effector of the
EGFR [27, 28]. Genome wide survey of multiple oncogene
amplifications found that EGFR were involved in the devel-
opment of NPC [29]. Recently, a report suggested that ec-
topic expression of AGK can enhance the expression of
VEGF and promote angiogenesis in HCC in vitro [18]. On
the basis of this evidence, we assume that high levels of
AGK may promote lymph node metastasis in NPC via
VEGF or/and EGFR. However, further investigation is re-
quired to confirm this hypothesis.
In summary, this is the first study to highlight the clinical
significance of AGK in NPC. High AGK expression was as-
sociated with poorer survival and lymph node metastasis in
patients with NPC. Comprehensive analysis of the molecular
mechanisms underlying the role of AGK in the development
and progression of NPC is warranted.
Conclusions
This study demonstrates that overexpression of AGK corre-
lates with disease progression in NPC, indicating that AGK
has value as a novel prognostic biomarker. Further exploration
Table 4 Multivariate logistic regression analysis of factors associated with lymph node metastasis in NPC
Parameters B S.E. Wald P Exp (B) 95.0 % CI for Exp (B)
Lower Upper
AGK expression (high vs low) 2.362 1.102 4.594 0.032 5.613 1.224 92.034
Histological differentiation (U vs D) 1.462 0.655 4.986 0.026 4.315 1.196 15.573
T stage (T1–2 vs T3–4) 1.697 0.697 5.927 0.015 5.458 1.392 21.400
Age, years (≥45 vs <45) −1.278 0.680 3.528 0.060 0.279 0.073 1.057
Gender (M vs F) −0.043 0.684 0.004 0.950 0.958 0.251 3.660
Table 3 Univariate and multivariate Cox regression analysis of the association between various prognostic features and overall survival in
nasopharyngeal cancer
Variable Univariate Multivariate
P Regression coefficient (SE) P Relative risk 95 % CI
AGK expression (high vs low) 0.001 3.298 (1.031) 0.041 8.882 1.097–7.929
T stage (T1 vs 2 vs 3 vs 4) 0.010 1.031 (0.401) 0.510 0.633 0.162–2.471
N stage (N1 vs 2 vs 3 vs 4) <0.001 1.066 (0.281) 0.300 1.447 0.720–2.909
M stage (M0 vs 1) <0.001 2.414 (0.532) 0.010 4.616 1.439–4.878
Clinical stage (I vs II vs III vs IV) 0.001 2.014 (0.606) 0.040 6.163 1.083–5.090
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of the exact function of AGK during the progression of NPC is
required.
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